Cargando…
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells
Human mesenchymal stromal/stem cells (hMSCs) emerged as a promising therapeutic tool for ischemic disorders, due to their ability to regenerate damaged tissues, promote angiogenesis and reduce inflammation, leading to encouraging, but still limited results. The outcomes in clinical trials exploring...
Autores principales: | Cuomo, Francesca, Coppola, Antonietta, Botti, Chiara, Maione, Ciro, Forte, Amalia, Scisciola, Lucia, Liguori, Giuseppina, Caiafa, Ilaria, Ursini, Matilde Valeria, Galderisi, Umberto, Cipollaro, Marilena, Altucci, Lucia, Cobellis, Gilda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895792/ https://www.ncbi.nlm.nih.gov/pubmed/29643458 http://dx.doi.org/10.1038/s41598-018-24221-5 |
Ejemplares similares
-
Author Correction: Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells
por: Cuomo, Francesca, et al.
Publicado: (2020) -
SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs
por: Chiara, Botti, et al.
Publicado: (2014) -
Corrigendum to “SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs”
por: Botti, Chiara, et al.
Publicado: (2015) -
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders
por: Dell’Aversana, Carmela, et al.
Publicado: (2019) -
Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy
por: Cuomo, Francesca, et al.
Publicado: (2019)